BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17878103)

  • 1. [Adjuvant treatment of head and neck cancers: advances and challenges].
    Bernier J
    Bull Cancer; 2007 Sep; 94(9):823-7. PubMed ID: 17878103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant post-operative chemoradiotherapy in head and neck cancer: a standard of care?
    Posner MR
    Oncologist; 2005 Mar; 10(3):174-5. PubMed ID: 15793219
    [No Abstract]   [Full Text] [Related]  

  • 6. The chemoradiation paradigm in head and neck cancer.
    Seiwert TY; Salama JK; Vokes EE
    Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemotherapy and radiotherapy for head and neck cancer.
    Burri RJ; Lee NY
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapeutic management of locally advanced head and neck cancer.
    Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J; Domenge C; Ozsahin M; Matuszewska K; Lefèbvre JL; Greiner RH; Giralt J; Maingon P; Rolland F; Bolla M; Cognetti F; Bourhis J; Kirkpatrick A; van Glabbeke M;
    N Engl J Med; 2004 May; 350(19):1945-52. PubMed ID: 15128894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
    Bernier J; Vermorken JB; Koch WM
    J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial.
    Kumar S; Pandey M; Lal P; Rastogi N; Maria Das KJ; Dimri K
    Radiother Oncol; 2005 May; 75(2):186-92. PubMed ID: 16086908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
    Medina JA; Rueda A; de Pasos AS; Contreras J; Cobo M; Moreno P; Benavides M; Villanueva A; Alba E
    Radiother Oncol; 2006 Apr; 79(1):34-8. PubMed ID: 16626826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of concurrent chemo-radiotherapy in patients with head and neck cancers: a review.
    Al-Sarraf MD
    Gulf J Oncolog; 2007 Jul; (2):8-16. PubMed ID: 20084719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.
    Bernier J; Pfister DG; Cooper JS
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):353-64. PubMed ID: 15979887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.